This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kim Richard Jones, MD, PhD; Mark Christian Weissler, MD

Arch Otolaryngol Head Neck Surg. 1990;116(3):304-309.

Abstract
• To determine whether perioperative blood transfusion affected the recurrence rate of squamous cell cancer of the head and neck, we performed a retrospective study of all patients with stage III and IV disease treated surgically at the University of North Carolina, Chapel Hill, between 1983 and 1986. Those who recurred were compared with those who did not in regard to 16 prognostic variables, including whether or not they had received a perioperative blood transfusion. Analyzing each variable separately, five were significantly related to recurrence. These were (1) surgical margin status, (2) stage, (3) presence of pathologically positive nodes, (4) blood transfusion status, and (5) type of treatment. However, because several of these variables were clearly interrelated, the same data were subjected to a multivariate regression analysis specifically designed to identify significant prognostic variables independent of their association with other variables. By this analysis, only margin status and the presence or absence of a blood transfusion were statistically significant predictors of recurrence.

(Arch Otolaryngol Head Neck Surg. 1990;116:304-309)

Author Affiliations
From the Department of Surgery, Division of Otolaryngology/Head and Neck Surgery, University of North Carolina, Chapel Hill.

Footnotes
Accepted for publication October 19, 1989.

Read before the annual meeting of the American Society for Head and Neck Surgery, San Francisco, Calif, April 5, 1989.

Reprint requests to University of North Carolina, Division of Otolaryngology/Head and Neck Surgery, CB 7070, Burnett-Womack Bldg, Chapel Hill, NC 27514-7070 (Dr Jones).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
Abbrederis et al.
Ann. Thorac. Surg. 2006;82:293-297.
ABSTRACT | FULL TEXT  

Incidence of anemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer
Voelter et al.
Ann. Thorac. Surg. 2004;78:1037-1041.
ABSTRACT | FULL TEXT  

Autologous and Heterologous Blood Transfusion in Head and Neck Cancer Surgery
Moir et al.
Arch Otolaryngol Head Neck Surg 1999;125:864-868.
ABSTRACT | FULL TEXT  

Blood Transfusion as a Risk Factor for Death in Stage III and IV Operative Laryngeal Cancer
McCulloch et al.
Arch Otolaryngol Head Neck Surg 1995;121:1227-1235.
ABSTRACT  

The Effect of Perioperative Blood Transfusion on Survival in Head and Neck Cancer
Schuller et al.
Arch Otolaryngol Head Neck Surg 1994;120:711-716.
ABSTRACT  

Long-term Survival After Surgical Resection for Recurrent Nasopharyngeal Cancer After Radiotherapy Failure
Fee et al.
Arch Otolaryngol Head Neck Surg 1991;117:1233-1236.
ABSTRACT